Healthcare -
Biotechnology - NASDAQ - US
$ 4.39
-1.84 %
$ 37.9 M
Market Cap
-0.36
P/E
KPTI - LONG-TERM DEBT
Long-term Debt KPTI - Karyopharm Therapeutics Inc.
170 M
LAST VALUE
-1.87%
2 YEAR CAGR
6.63%
5 YEAR CAGR
0.00%
10 YEAR CAGR